Gentian Diagnostics ASA (GENT.OL)

NOK 39.0

(0.0%)

Operating Expenses Summary of Gentian Diagnostics ASA

Gentian Diagnostics ASA's latest annual operating expenses in 2023 was 88.35 Million NOK , up 0.12% from previous year.
Gentian Diagnostics ASA's latest quarterly operating expenses in 2024 Q2 was 17.13 Million NOK , down -3.42% from previous quarter.
Gentian Diagnostics ASA reported a annual operating expenses of 72.23 Million NOK in annual operating expenses 2022, up 15.04% from previous year.
Gentian Diagnostics ASA reported a annual operating expenses of 62.79 Million NOK in annual operating expenses 2021, up 17.14% from previous year.
Gentian Diagnostics ASA reported a quarterly operating expenses of 14.32 Million NOK for 2024 Q3, down -16.7% from previous quarter.
Gentian Diagnostics ASA reported a quarterly operating expenses of 17.73 Million NOK for 2024 Q1, down -3.0% from previous quarter.

Annual Operating Expenses Chart of Gentian Diagnostics ASA (2023 - 2013)

Historical Annual Operating Expenses of Gentian Diagnostics ASA (2023 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2023	88.35 Million NOK	0.12%
2022	72.23 Million NOK	15.04%
2021	62.79 Million NOK	17.14%
2020	53.6 Million NOK	7.95%
2019	49.65 Million NOK	-9.98%
2018	55.16 Million NOK	21.5%
2017	45.4 Million NOK	33.79%
2016	33.93 Million NOK	51.98%
2015	22.32 Million NOK	7.94%
2014	20.68 Million NOK	24.55%
2013	16.6 Million NOK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	17.13 Million NOK	-3.42%
2024 Q3	14.32 Million NOK	-16.7%
2024 Q1	17.73 Million NOK	-3.0%
2023 Q4	18.28 Million NOK	2.63%
2023 FY	72.32 Million NOK	0.12%
2023 Q1	19.29 Million NOK	5.25%
2023 Q3	17.81 Million NOK	-1.6%
2023 Q2	18.1 Million NOK	-6.17%
2022 Q3	19.02 Million NOK	-3.33%
2022 Q1	15.19 Million NOK	-26.61%
2022 FY	72.23 Million NOK	15.04%
2022 Q4	18.33 Million NOK	-3.65%
2022 Q2	19.68 Million NOK	29.57%
2021 Q3	12.97 Million NOK	-19.06%
2021 FY	62.79 Million NOK	17.14%
2021 Q2	16.02 Million NOK	-16.28%
2021 Q1	19.14 Million NOK	201.35%
2021 Q4	20.7 Million NOK	59.58%
2020 Q2	15.53 Million NOK	-1.2%
2020 Q1	15.72 Million NOK	92.41%
2020 FY	53.6 Million NOK	7.95%
2020 Q4	6.35 Million NOK	-60.28%
2020 Q3	15.99 Million NOK	2.93%
2019 FY	49.65 Million NOK	-9.98%
2019 Q4	8.17 Million NOK	-42.25%
2019 Q3	14.15 Million NOK	3.35%
2019 Q1	13.63 Million NOK	-6.54%
2019 Q2	13.69 Million NOK	0.4%
2018 Q4	14.59 Million NOK	-10.52%
2018 FY	55.16 Million NOK	21.5%
2018 Q1	12.64 Million NOK	4.81%
2018 Q2	11.62 Million NOK	-8.05%
2018 Q3	16.3 Million NOK	40.33%
2017 Q4	12.05 Million NOK	6.35%
2017 Q2	9.82 Million NOK	-19.28%
2017 Q1	12.17 Million NOK	0.31%
2017 FY	45.4 Million NOK	33.79%
2017 Q3	11.33 Million NOK	15.36%
2016 Q4	12.13 Million NOK	35.8%
2016 Q2	6.03 Million NOK	-11.5%
2016 Q1	6.82 Million NOK	9.51%
2016 FY	33.93 Million NOK	51.98%
2016 Q3	8.93 Million NOK	48.09%
2015 FY	22.32 Million NOK	7.94%
2015 Q3	5.63 Million NOK	0.0%
2015 Q4	6.22 Million NOK	10.61%
2014 FY	20.68 Million NOK	24.55%
2013 FY	16.6 Million NOK	0.0%

Peer Operating Expenses Comparison of Gentian Diagnostics ASA

Name	Operating Expenses	Operating Expenses Difference
Lifecare AS	45.18 Million NOK	-95.564%
Medistim ASA	277.38 Million NOK	68.146%